Anastasios G P Konstas Selected Research

Timolol (Blocadren)

1/2018	Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.
6/2016	Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma.
6/2014	24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
9/2013	Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.
10/2012	Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma.
4/2012	Overview of the [corrected] travoprost /timolol BAK-free fixed combination.
2/2010	Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.
2/2009	Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
10/2008	Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
11/2006	24-Hour control with a latanoprost-timolol fixed combination vs timolol alone.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasios G P Konstas Research Topics

Disease

28	Glaucoma 09/2022 - 03/2003
20	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2022 - 06/2002
9	Exfoliation Syndrome 01/2021 - 12/2002
6	Cataract (Cataracts) 01/2016 - 12/2002
4	Ocular Hypertension (Glaucoma, Suspect) 01/2015 - 07/2008
4	Hyperemia 04/2007 - 10/2004
2	Pruritus (Itching) 11/2006 - 07/2005
1	Neuroinflammatory Diseases 09/2021
1	Refractive Errors (Refractive Error) 01/2019
1	Meibomian Gland Dysfunction 06/2018
1	Neovascular Glaucoma 01/2018
1	Cicatrix (Scar) 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2018
1	Fibrosis (Cirrhosis) 04/2016
1	Blister (Bulla) 04/2016
1	Surgical Wound 01/2016
1	Endophthalmitis (Ophthalmia) 01/2016
1	Exophthalmos (Proptosis) 07/2015
1	Optic Nerve Diseases (Optic Neuropathy) 07/2015
1	Graves Ophthalmopathy 07/2015
1	Acromegaly 07/2014
1	Blindness (Hysterical Blindness) 05/2014
1	Disease Progression 10/2013
1	Macular Edema 09/2013
1	Retinitis 09/2013
1	Retinal Vasculitis 09/2013
1	Vitreous Hemorrhage 09/2013
1	Aneurysm (Aneurysms) 09/2013
1	Coronary Disease (Coronary Heart Disease) 07/2011
1	Hypertension (High Blood Pressure) 07/2011
1	Stroke (Strokes) 07/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2011
1	Hypertrichosis 01/2008
1	Pathologic Processes 11/2005
1	Infections 06/2002

Drug/Important Bio-Agent (IBA)

15	Timolol (Blocadren)FDA LinkGeneric 01/2018 - 06/2002
15	Latanoprost (Xalatan)FDA Link 06/2014 - 06/2002
10	Travoprost (Travatan)FDA Link 01/2015 - 03/2006
4	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2018 - 11/2008
3	ProstaglandinsIBA 01/2018 - 11/2008
3	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 09/2013 - 12/2003
3	dorzolamide (Trusopt)FDA LinkGeneric 10/2008 - 07/2003
2	Retinaldehyde (Retinal)IBA 09/2021 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2005
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2018 - 05/2006
2	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2018 - 06/2014
2	tafluprostIBA 06/2016 - 12/2013
2	SolutionsIBA 09/2013 - 10/2012
2	Bimatoprost (Lumigan)FDA Link 02/2010 - 02/2005
2	Tissue Inhibitor of Metalloproteinase-2IBA 02/2006 - 03/2003
1	SirtuinsIBA 09/2022
1	Sirtuin 1IBA 09/2022
1	AdiponectinIBA 09/2022
1	Protein AggregatesIBA 01/2021
1	ApelinIBA 01/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2018
1	Vascular Endothelial Growth FactorsIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Ranibizumab (Lucentis)FDA Link 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 04/2016
1	Drinking WaterIBA 03/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	SteroidsIBA 07/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2014
1	brinzolamide (Azopt)FDA Link 09/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2013
1	Dihydrotachysterol (AT 10)IBA 09/2013
1	carbomerIBA 10/2012
1	CholesterolIBA 07/2011
1	CatalaseIBA 10/2008
1	PeroxidesIBA 10/2008
1	AntioxidantsIBA 10/2008
1	hydroxide ionIBA 07/2008
1	trabecular meshwork-induced glucocorticoid response proteinIBA 04/2008
1	GelatinasesIBA 02/2006
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2006
1	Immunoglobulin G (IgG)IBA 11/2003
1	AntibodiesIBA 11/2003
1	Tissue Inhibitor of Metalloproteinase-1IBA 03/2003
1	Matrix Metalloproteinases (MMPs)IBA 03/2003
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2002
1	UreaseIBA 06/2002

Therapy/Procedure

15	Therapeutics 06/2018 - 06/2002
4	Lasers (Laser) 01/2019 - 05/2006
3	Phacoemulsification 02/2006 - 12/2002
2	Corneal Transplantation (Keratoplasty) 05/2014 - 10/2013
1	Filtering Surgery 01/2018
1	Off-Label Use 01/2018
1	Slit Lamp 04/2016
1	Percutaneous Collagen Induction 04/2016
1	Intravitreal Injections 01/2016
1	Intraocular Lenses (Intraocular Lens) 01/2016
1	Surgical Decompression 07/2015
1	Decompression 07/2015
1	Operative Surgical Procedures 07/2015
1	Vitrectomy 09/2013
1	Organ Transplantation 05/2011
1	Trabeculectomy (Trabeculoplasty) 05/2006